MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Aktis Oncology
Finance & Acquisition: Aktis
Parents
Aktis Oncology
Children
*Designed for high tumor penetration and long residence time, Aktis Oncology's molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing side effects of treatment.
*This approach would also enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes
2021: Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals
2021: Series A led by MPM Capital, with EcoR1 Capital and Vida Ventures, with participation from Octagon Capital, TCG Crossover, Novartis and Bristol Myers Squibb.
2022: Aktis makes waves with $84M extension as 3 big pharmas channel funds to radiopharmaceutical pipeline
2024: Aktis sees Big Pharma backers return for $175M series B
Jumps
*Key People: Aktis
Organization & Developments: Aktis